Critical Insights From IDEAYA Biosciences Analyst Ratings: What You Need To Know
Critical Insights From IDEAYA Biosciences Analyst Ratings: What You Need To Know
来自IDEAYA生物科学分析师评级的关键见解：你需要知道的
In the latest quarter, 7 analysts provided ratings for IDEAYA Biosciences (NASDAQ:IDYA), showcasing a mix of bullish and bearish perspectives.
在最近一个季度中，7位分析师为IDEAYA Biosciences（纳斯达克股票代码：IDYA）提供了评级，显示了看涨和看跌的观点。
The table below provides a snapshot of their recent ratings, showcasing how sentiments have evolved over the past 30 days and comparing them to the preceding months.
下表简要介绍了他们最近的评级，展示了过去30天情绪的演变，并将其与前几个月进行了比较。
Analysts provide deeper insights through their assessments of 12-month price targets, revealing an average target of $40.86, a high estimate of $44.00, and a low estimate of $36.00. Surpassing the previous average price target of $37.75, the current average has increased by 8.24%.
分析师通过对12个月目标股价的评估提供了更深入的见解，显示平均目标价为40.86美元，最高估计为44.00美元，低估值为36.00美元。超过了之前的平均目标股价37.75美元，目前的平均价格上涨了8.24％。
Decoding Analyst Ratings: A Detailed Look
解码分析师评级：详细介绍
An in-depth analysis of recent analyst actions unveils how...
对分析师近期行为的深...
登录免费看全文
登录/注册
译文内容由第三方软件翻译。
以上内容仅用作资讯或教育之目的，不构成与富途相关的任何投资建议。富途竭力但不能保证上述全部内容的真实性、准确性和原创性。